Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of PTEN Hamartoma Tumor Syndrome in an Adult Patient With a Novel RECQL4 Mutation
- PMID: 35220242
- DOI: 10.21873/anticanres.15619
Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of PTEN Hamartoma Tumor Syndrome in an Adult Patient With a Novel RECQL4 Mutation
Abstract
Background: Phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome (PHTS) is a complex disorder. Carriers develop hamartomatous tumors, with an increased risk for developing malignant tumors in multiple organs. Surveillance to facilitate the early detection and treatment of malignancies is extremely important.
Case report: A 31-year-old male presented with a 10 cm left lobe thyroid gland mass. After fine needle aspiration a left hemithyroidectomy was performed, which demonstrated a minimally invasive follicular thyroid carcinoma (FTC, stage pT3a) and microscopic classical papillary thyroid carcinoma (PTC) in the background of about 50 separate adenomatous nodules (0.2-5 mm). Immunostaining showed loss of PTEN protein in the minimally invasive FTC and in all of the nodules tested, with uninvolved parenchyma serving as an internal control. Kaiser Permanente Northern California (KPNC) Hereditary Cancer Panel, testing for 62 genes, was performed and showed germline mutations in PTEN and RecQ like helicase 4 (RECQL4) genes. Completion thyroidectomy subsequently performed demonstrated about 60 follicular cell-derived adenomatous nodules (0.3-10 mm). Genetic counseling and evaluation documented Cowden syndrome (CS) in the family. Thus, PHTS was confirmed.
Conclusion: This report documents synchronous FTC and PTC in a background of multiple follicular adenomatous nodules with a novel RECQL4 mutation in an adult patient with PHTS. As such, documented the loss of PTEN protein in a thyroid gland affected by multiple adenomatous nodules aided in diagnosing PHTS.
Keywords: Cowden syndrome; Minimally invasive follicular thyroid carcinoma; PTEN gene mutation; PTEN hamartoma tumor syndrome; RECQL4 gene; germline mutation; surveillance.
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Similar articles
-
Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.Thyroid. 2011 Feb;21(2):135-44. doi: 10.1089/thy.2010.0226. Epub 2010 Dec 29. Thyroid. 2011. PMID: 21190448
-
Clinicopathologic features of thyroid nodules with PTEN mutations on preoperative testing.Endocr Relat Cancer. 2022 Jul 19;29(9):513-520. doi: 10.1530/ERC-22-0061. Print 2022 Sep 1. Endocr Relat Cancer. 2022. PMID: 35723418
-
Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.J Clin Endocrinol Metab. 2014 Jul;99(7):E1316-21. doi: 10.1210/jc.2014-1225. Epub 2014 Apr 8. J Clin Endocrinol Metab. 2014. PMID: 24712574 Free PMC article.
-
Breast cancer risk and clinical implications for germline PTEN mutation carriers.Breast Cancer Res Treat. 2017 Aug;165(1):1-8. doi: 10.1007/s10549-015-3665-z. Epub 2015 Dec 23. Breast Cancer Res Treat. 2017. PMID: 26700035 Review.
-
Genodermatosis Affecting the Skin and Mucosa of the Head and Neck: Clinicopathologic, Genetic, and Molecular Aspect--PTEN-Hamartoma Tumor Syndrome/Cowden Syndrome.Head Neck Pathol. 2016 Jun;10(2):131-8. doi: 10.1007/s12105-016-0708-7. Epub 2016 Mar 14. Head Neck Pathol. 2016. PMID: 26975628 Free PMC article. Review.
Cited by
-
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review.Cancers (Basel). 2022 Jul 22;14(15):3560. doi: 10.3390/cancers14153560. Cancers (Basel). 2022. PMID: 35892820 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials